Latest Security News

Healius Limited has announced a fully franked special dividend of 41.3 cents per share totaling approximately $300 million, alongside a new $300 million three-year syndicated bank facility replacing its previous $680 million arrangement.

Finexia Financial Group announces the resignation of Interim CEO Marc Duncan as the Board intensifies its review of credit operations and pursues ASX securities reinstatement.

A shareholder has lodged an application with the Takeovers Panel challenging FBR Limited’s upcoming extraordinary general meeting resolutions related to significant share placements and funding arrangements with Fidelity International.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Kinatico (ASX:KYP) has upgraded its SaaS revenue forecast for the second half of FY25 to $8.3 million, driven by strong demand for its compliance and credential validation software. The company’s recent sales hires and April launch of Kinatico Compliance underpin this optimistic outlook.

Pact Group Holdings has received conditional approval from the ASX for its voluntary delisting, pending shareholder endorsement at an upcoming extraordinary general meeting scheduled for 12 June 2025.

Citigold Corporation Limited has had its trading suspension lifted immediately following the submission of its reissued half year financial report and responses to ASX compliance queries.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.

Infinity Mining has executed a binding agreement to divest its Leonora Goldfields Project interest to U Resource, which will transfer it to Evergreen Lithium (ASX: EG1). Infinity retains exposure through a substantial EG1 shareholding while refocusing on its core assets.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

FXG has announced a $17 million two-tranche placement priced at A$0.155 per share, aimed at advancing drilling and exploration activities in Alaska. The second tranche awaits shareholder approval, marking a pivotal funding milestone for the company.